JP2014509313A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014509313A5 JP2014509313A5 JP2013552124A JP2013552124A JP2014509313A5 JP 2014509313 A5 JP2014509313 A5 JP 2014509313A5 JP 2013552124 A JP2013552124 A JP 2013552124A JP 2013552124 A JP2013552124 A JP 2013552124A JP 2014509313 A5 JP2014509313 A5 JP 2014509313A5
- Authority
- JP
- Japan
- Prior art keywords
- nasal
- nose
- powder
- ingested
- sucking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000001331 nose Anatomy 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 1
- 239000012876 carrier material Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 239000007923 nasal drop Substances 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 239000007922 nasal spray Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE102011009961A DE102011009961A1 (de) | 2011-02-01 | 2011-02-01 | 7-Azaindolderivate |
| DE102011009961.1 | 2011-02-01 | ||
| PCT/EP2012/000067 WO2012104007A2 (de) | 2011-02-01 | 2012-01-09 | 7-azaindolderivate |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014509313A JP2014509313A (ja) | 2014-04-17 |
| JP2014509313A5 true JP2014509313A5 (enExample) | 2016-01-21 |
| JP5891249B2 JP5891249B2 (ja) | 2016-03-22 |
Family
ID=45554609
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013552124A Expired - Fee Related JP5891249B2 (ja) | 2011-02-01 | 2012-01-09 | ７−アザインドール誘導体 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US8981101B2 (enExample) |
| EP (3) | EP2670748B1 (enExample) |
| JP (1) | JP5891249B2 (enExample) |
| KR (1) | KR20140014158A (enExample) |
| CN (3) | CN105712991B (enExample) |
| AR (1) | AR085110A1 (enExample) |
| AU (1) | AU2012213775B2 (enExample) |
| BR (1) | BR112013019028A2 (enExample) |
| CA (2) | CA3082435A1 (enExample) |
| DE (1) | DE102011009961A1 (enExample) |
| EA (1) | EA201300873A1 (enExample) |
| ES (3) | ES2861048T3 (enExample) |
| HK (1) | HK1226394A1 (enExample) |
| IL (1) | IL227689A0 (enExample) |
| MX (1) | MX2013008212A (enExample) |
| SG (1) | SG192133A1 (enExample) |
| WO (1) | WO2012104007A2 (enExample) |
| ZA (1) | ZA201306542B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG186855A1 (en) * | 2010-06-28 | 2013-02-28 | Merck Patent Gmbh | 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| DE102010053347A1 (de) * | 2010-12-03 | 2012-06-06 | Merck Patent Gmbh | 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren |
| DE102011009961A1 (de) * | 2011-02-01 | 2012-08-02 | Merck Patent Gmbh | 7-Azaindolderivate |
| ES2606638T3 (es) * | 2012-02-21 | 2017-03-24 | Merck Patent Gmbh | Derivados de furopiridina |
| DE102012019369A1 (de) | 2012-10-02 | 2014-04-03 | Merck Patent Gmbh | 7-Azaindolderivat |
| FR3001219A1 (fr) * | 2013-01-22 | 2014-07-25 | Centre Nat Rech Scient | Inhibiteurs de kinases |
| GB201303109D0 (en) | 2013-02-21 | 2013-04-10 | Domainex Ltd | Novel pyrimidine compounds |
| US20140303121A1 (en) | 2013-03-15 | 2014-10-09 | Plexxikon Inc. | Heterocyclic compounds and uses thereof |
| RU2680100C9 (ru) * | 2013-03-15 | 2019-04-18 | Плексксикон Инк. | Гетероциклические соединения и их применения |
| TW201613916A (en) | 2014-06-03 | 2016-04-16 | Gilead Sciences Inc | TANK-binding kinase inhibitor compounds |
| ES2881195T3 (es) | 2014-09-26 | 2021-11-29 | Gilead Sciences Inc | Derivados de aminotriazina útiles como compuestos inhibidores de quinasas que se unen a TANK |
| WO2016141279A1 (en) * | 2015-03-04 | 2016-09-09 | Dana-Farber Cancer Institute, Inc. | Salicylate inhibitors of melk and methods of use |
| WO2016164641A1 (en) * | 2015-04-08 | 2016-10-13 | Plexxikon Inc. | Compounds and methods for kinase modulation, and indications therefor |
| US9988391B2 (en) * | 2015-06-29 | 2018-06-05 | Merck Patent Gmbh | TBK/IKK inhibitor compounds and uses thereof |
| CA3006772A1 (en) | 2015-12-17 | 2017-06-22 | Gilead Sciences, Inc. | Tank-binding kinase inhibitor compounds |
| WO2017102091A1 (en) | 2015-12-18 | 2017-06-22 | Bayer Pharma Aktiengesellschaft | Heteroarylbenzimidazole compounds |
| CN105906608B (zh) * | 2016-05-03 | 2018-10-19 | 中山大学 | 8-氨基喹啉-松果体素杂联体及其药物组合物 |
| WO2017207534A1 (en) | 2016-06-03 | 2017-12-07 | Bayer Pharma Aktiengesellschaft | Substituted heteroarylbenzimidazole compounds |
| GB201702947D0 (en) | 2017-02-23 | 2017-04-12 | Domainex Ltd | Novel compounds |
| US11180495B2 (en) * | 2017-06-19 | 2021-11-23 | Abbisko Therapeutics Co., Ltd. | Nitrogen heteroaryl derivative having CSF1R inhibitory activity, and preparation method therefor and application thereof |
| JP7675519B2 (ja) | 2017-10-13 | 2025-05-13 | オプナ バイオ ソシエテ アノニム | キナーゼを調節するための化合物の固体形態 |
| US12448374B2 (en) | 2018-06-07 | 2025-10-21 | Disarm Therapeutics, Inc. | Inhibitors of SARM1 |
| ES3028093T3 (en) | 2018-06-07 | 2025-06-18 | Disarm Therapeutics Inc | Inhibitors of sarm1 |
| KR20200046680A (ko) * | 2018-10-25 | 2020-05-07 | 한국과학기술원 | Pdk1 저해제를 포함하는 역노화 유도용 조성물 |
| WO2025016273A1 (zh) * | 2023-07-14 | 2025-01-23 | 拜西欧斯（北京）生物技术有限公司 | 异喹啉衍生物、包含其的药物组合物以及它们的用途 |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
| GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
| JP2003500397A (ja) | 1999-05-19 | 2003-01-07 | スミスクライン ビーチャム パブリック リミテッド カンパニー | Ｍｒｓ阻害剤としての２−ｎｈ−ピリドンおよびピリミドン |
| CA2545942C (en) | 2003-11-14 | 2012-07-10 | Lorus Therapeutics Inc. | Aryl imidazoles and their use as anti-cancer agents |
| SE0303180D0 (sv) | 2003-11-26 | 2003-11-26 | Astrazeneca Ab | Novel compounds |
| CN100569772C (zh) * | 2004-03-30 | 2009-12-16 | 沃泰克斯药物股份有限公司 | 用作jak和其它蛋白激酶抑制剂的氮杂吲哚 |
| TWI372624B (en) | 2004-03-30 | 2012-09-21 | Vertex Pharma | Azaindoles useful as inhibitors of jak and other protein kinases |
| FR2868422B1 (fr) * | 2004-03-31 | 2006-07-14 | Aventis Pharma Sa | Nouveaux derives pyrrolo(2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases |
| JP2008502687A (ja) * | 2004-06-14 | 2008-01-31 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
| US7709645B2 (en) | 2004-07-27 | 2010-05-04 | Sgx Pharmaceuticals, Inc. | Pyrrolo-pyridine kinase modulators |
| US7855205B2 (en) | 2004-10-29 | 2010-12-21 | Janssen Pharmaceutica Nv | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
| US7511056B2 (en) | 2004-11-10 | 2009-03-31 | Eli Lilly And Company | TGF-β inhibitors |
| JP4954086B2 (ja) * | 2004-12-08 | 2012-06-13 | グラクソスミスクライン・リミテッド・ライアビリティ・カンパニー | １ｈ−ピロロ［２，３−ｂ］ピリジン |
| MX2007012448A (es) | 2005-04-06 | 2007-10-19 | Astrazeneca Ab | Heterociclos sustituidos y su uso como inhibidores de chk1, pdk1 y pak. |
| US7541367B2 (en) | 2005-05-31 | 2009-06-02 | Janssen Pharmaceutica, N.V. | 3-benzoimidazolyl-pyrazolopyridines useful in treating kinase disorders |
| JP2007099640A (ja) * | 2005-09-30 | 2007-04-19 | Tsumura & Co | 含窒素複素環化合物、その製造方法およびそれを用いた医薬組成物 |
| CN101374839A (zh) * | 2006-01-17 | 2009-02-25 | 沃泰克斯药物股份有限公司 | 适用作詹纳斯激酶抑制剂的吖吲哚类 |
| RU2453548C2 (ru) | 2006-01-17 | 2012-06-20 | Вертекс Фармасьютикалз Инкорпорейтед | Азаиндолы, полезные в качестве ингибиторов янус-киназ |
| DE102006012617A1 (de) | 2006-03-20 | 2007-09-27 | Merck Patent Gmbh | 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| US20100267707A1 (en) | 2006-06-22 | 2010-10-21 | Merck Sharp & Dohme Corp. | Tyrosine Kinase Inhibitors |
| US8778977B2 (en) | 2006-06-30 | 2014-07-15 | Sunesis Pharmaceuticals, Inc. | Pyridinonyl PDK1 inhibitors |
| JP2010514693A (ja) | 2006-12-22 | 2010-05-06 | ノバルティス アーゲー | Ｐｄｋ１阻害のためのキナゾリン |
| JP2010521459A (ja) | 2007-03-13 | 2010-06-24 | メルク・シャープ・エンド・ドーム・コーポレイション | ヤヌスキナーゼ及び／又は３−ホスホイノシチド依存性プロテインキナーゼ−１のインヒビター |
| ES2395581T3 (es) | 2007-06-20 | 2013-02-13 | Merck Sharp & Dohme Corp. | Inhibidores de quinasas janus |
| DE102007028515A1 (de) | 2007-06-21 | 2008-12-24 | Merck Patent Gmbh | 6-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
| WO2009054941A1 (en) | 2007-10-25 | 2009-04-30 | Merck & Co., Inc. | Therapeutic compounds |
| AU2009218607B2 (en) * | 2008-02-25 | 2014-02-13 | F. Hoffmann-La Roche Ag | Pyrrolopyrazine kinase inhibitors |
| DE102008025751A1 (de) * | 2008-05-29 | 2009-12-03 | Merck Patent Gmbh | 4-(1H-Pyrrolo[2,3-b]pyridin-3-yl)-pyridin-2-ylamin-derivate |
| DE102008031517A1 (de) * | 2008-07-03 | 2010-01-07 | Merck Patent Gmbh | Pyrrolopyridinyl-pyrimidin-2-yl-amin-derivate |
| DE102008038221A1 (de) * | 2008-08-18 | 2010-02-25 | Merck Patent Gmbh | 7-Azaindolderivate |
| CN101723936B (zh) | 2008-10-27 | 2014-01-15 | 上海睿星基因技术有限公司 | 激酶抑制剂及其在药学中的用途 |
| DE102009019962A1 (de) * | 2009-05-05 | 2010-11-11 | Merck Patent Gmbh | 3-([1,2,3]Triazol-4-yl)-pyrrolo[2,3-b]pyridinderivate |
| EP2576549A4 (en) * | 2010-05-24 | 2013-12-18 | Univ Rochester | BICYCLIC HETEROARYLATES FORMING KINASE INHIBITORS AND METHODS OF USE |
| SG186855A1 (en) * | 2010-06-28 | 2013-02-28 | Merck Patent Gmbh | 2,4- diaryl - substituted [1,8] naphthyridines as kinase inhibitors for use against cancer |
| DE102010053347A1 (de) | 2010-12-03 | 2012-06-06 | Merck Patent Gmbh | 3-Hetaryl-substituierte Pyrrolo[2,3-b] pyridin-derivative als PDK1-Inhibitoren |
| DE102011009961A1 (de) * | 2011-02-01 | 2012-08-02 | Merck Patent Gmbh | 7-Azaindolderivate |
-
2011
- 2011-02-01 DE DE102011009961A patent/DE102011009961A1/de not_active Withdrawn
-
2012
- 2012-01-09 CN CN201610048764.7A patent/CN105712991B/zh not_active Expired - Fee Related
- 2012-01-09 MX MX2013008212A patent/MX2013008212A/es not_active Application Discontinuation
- 2012-01-09 EP EP12701437.1A patent/EP2670748B1/de not_active Not-in-force
- 2012-01-09 ES ES16002047T patent/ES2861048T3/es active Active
- 2012-01-09 CA CA3082435A patent/CA3082435A1/en not_active Abandoned
- 2012-01-09 JP JP2013552124A patent/JP5891249B2/ja not_active Expired - Fee Related
- 2012-01-09 BR BR112013019028A patent/BR112013019028A2/pt not_active IP Right Cessation
- 2012-01-09 SG SG2013056726A patent/SG192133A1/en unknown
- 2012-01-09 EP EP14000623.0A patent/EP2746281B1/de not_active Not-in-force
- 2012-01-09 CA CA2826051A patent/CA2826051C/en not_active Expired - Fee Related
- 2012-01-09 ES ES14000623.0T patent/ES2634643T3/es active Active
- 2012-01-09 KR KR1020137022887A patent/KR20140014158A/ko not_active Withdrawn
- 2012-01-09 EA EA201300873A patent/EA201300873A1/ru unknown
- 2012-01-09 EP EP16002047.5A patent/EP3133074B1/de not_active Not-in-force
- 2012-01-09 AU AU2012213775A patent/AU2012213775B2/en not_active Ceased
- 2012-01-09 CN CN201610048667.8A patent/CN105732617B/zh not_active Expired - Fee Related
- 2012-01-09 WO PCT/EP2012/000067 patent/WO2012104007A2/de not_active Ceased
- 2012-01-09 US US13/983,083 patent/US8981101B2/en not_active Expired - Fee Related
- 2012-01-09 CN CN201280007145.3A patent/CN103502247B/zh not_active Expired - Fee Related
- 2012-01-09 ES ES12701437.1T patent/ES2608317T3/es active Active
- 2012-02-01 AR ARP120100332A patent/AR085110A1/es not_active Application Discontinuation
-
2013
- 2013-07-29 IL IL227689A patent/IL227689A0/en active IP Right Grant
- 2013-08-30 ZA ZA2013/06542A patent/ZA201306542B/en unknown
-
2015
- 2015-02-06 US US14/616,113 patent/US9266887B2/en not_active Expired - Fee Related
-
2016
- 2016-01-05 US US14/987,946 patent/US9725446B2/en not_active Expired - Fee Related
- 2016-12-23 HK HK16114637.2A patent/HK1226394A1/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014509313A5 (enExample) | ||
| JP2013534227A5 (enExample) | ||
| JP2014526447A5 (enExample) | ||
| JP2013544781A5 (enExample) | ||
| JP2013541565A5 (enExample) | ||
| JP2015505541A5 (enExample) | ||
| Doktorovova et al. | Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation | |
| EA201590286A1 (ru) | Аэрозольное ингаляционное устройство | |
| RU2015121091A (ru) | Порошки для ингаляции с ультранизкой плотностью | |
| MX371521B (es) | Sistema de inhalacion de polvo seco. | |
| EA201591729A1 (ru) | Пригодные для вдыхания агломераты частиц пористого носителя и тонкоизмельченного лекарственного средства | |
| BR122021002471B8 (pt) | Dispositivo de distribuição de droga nasal | |
| WO2014012069A3 (en) | Dry powder drug delivery systems and methods | |
| MY191380A (en) | Stabilized fixed dose drug composition having mometasone and olopatadine | |
| EP4574191A3 (en) | Pulmonary delivery devices | |
| ATE527976T1 (de) | Vorrichtung zur lagerung, unmittelbaren zubereitung und verabreichung eines wirkstoffes | |
| JP2014530231A5 (enExample) | ||
| EA201700182A1 (ru) | Состав для повышения стабильности лекарственного препарата, содержащий по меньшей мере один сухой порошок, полученный распылительной сушкой | |
| MX2016007181A (es) | Medicamentos inhalables. | |
| EP4233874A3 (en) | Acetylsalicylic acid for reducing the risk of a thromboembolic event | |
| MD20160061A2 (ro) | Sistem de livrare a medicamentului compus din particule multiple | |
| MX2015009891A (es) | Composiciones farmaceuticas que comprenden particulas cristalinas de multicomponentes adecuadas para usar en terapia de inhalacion. | |
| HK1215167A1 (zh) | 可吸入药用组合物和含有该药用组合物的吸入器装置 | |
| WO2015006095A3 (en) | Apparatus for mixing and transferring medications | |
| RU2016103313A (ru) | Липидная наночастица с полимиксином |